Michael M. Tunney

97 Lisburn Road
Belfast, NIR, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial.

Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial.

Journal: American journal of respiratory and critical care medicine

Published: March 05, 2026

Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies.

Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies.

Journal: The European respiratory journal

Published: January 30, 2026

Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis.

Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 26, 2025

Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).

Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).

Journal: American journal of respiratory and critical care medicine

Published: July 15, 2025

Species-resolved exposure to fungi and bacteria, dust, and endotoxin during recycling of diverse waste types and systemic inflammatory response in workers.

Species-resolved exposure to fungi and bacteria, dust, and endotoxin during recycling of diverse waste types and systemic inflammatory response in workers.

Journal: Ecotoxicology and environmental safety

Published: July 06, 2025

Understanding Heterogeneity and Tolerance of Dual Candida albicans-Staphylococcus aureus Biofilms to Cold Atmospheric Plasma and Antimicrobial Combinations.

Understanding Heterogeneity and Tolerance of Dual Candida albicans-Staphylococcus aureus Biofilms to Cold Atmospheric Plasma and Antimicrobial Combinations.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: May 31, 2025

Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections.

Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections.

Journal: PloS one

Published: May 02, 2025

Molecular endotyping in people with bronchiectasis based on response to antibiotic treatment: iBEST study.

Molecular endotyping in people with bronchiectasis based on response to antibiotic treatment: iBEST study.

Journal: ERJ open research

Published: March 21, 2025

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.

Journal: The European respiratory journal

Published: December 12, 2024

Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.

Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.

Journal: Respiratory medicine

Published: January 31, 2024

Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa.

Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa.

Journal: Biofilm

Published: January 24, 2024

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis.

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis.

Journal: Journal of global antimicrobial resistance

Published: October 06, 2023

Showing 1-12 of 119

Last Updated: 09/26/2026